Most patients with rheumatoid arthritis or spondyloarthritis had significant antibody responses to COVID vaccine boosters, whether or not their immunomodulatory medications were held.

Here are the morning's top stories on Tuesday, November 19, 2024… If you’re one of the unlucky people who get bitten by a ...

Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting ...

Transforming Healthcare lecture series highlights efforts to expand therapy from cancer to autoimmune diseases While ...

Of concern was that in the age group of 5 to 12 years, only 15 per cent of patients were disability-free,” Raina told Financial Express.com. In the absence of access to treatment, there are reports of ...

We all age. And while humanity's life expectancy has increased dramatically in the modern era, we still struggle with the ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

A drug in advanced development for myasthenia gravis also showed promise as a treatment for primary Sjögren's syndrome, a ...

GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immunodeficiencies, infectious diseases and checkpoint-resistant cancers, and a subsidiary of Grifols, announced today ...

In this free webinar, learn how advanced robotics, digital tools and design of experiments (DoE) are revolutionizing viral vector manufacturing, optimization and quality control (QC) release testing.

There are fears of a rise in TBEV, West Nile and Usutu after birds and insects carrying viruses were found in England ...

In this study, our results uncover the function and mechanism of CHMP5 in the regulation of cell senescence and bone formation in osteogenic cells. Deletion of Chmp5 causes endolysosomal dysfunction ...